Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2020; 52(22): 3480-3484
DOI: 10.1055/s-0040-1707344
DOI: 10.1055/s-0040-1707344
paper
Scalable Synthesis of 3-Ethyl-4-methyl-1,5-dihydro-2H-pyrrol-2-one: An Important Building Block of the Antidiabetic Drug Glimepiride
A.A.P. and A.L.K. thank the University Grants Commission (UGC), New Delhi and N.B.P. thanks the Council of Scientific and Industrial Research (CSIR), New Delhi for the award of research fellowships. The authors thank CSIR, New Delhi for financial support as part of the XII Year Plan Programme under title ORIGIN (CSC-0108) and ACT (CSC-0301).Further Information
Publication History
Received: 18 February 2020
Accepted after revision: 25 June 2020
Publication Date:
04 August 2020 (online)
Abstract
A four-step, practical, and easily scalable synthesis of 3-ethyl-4-methyl-1,5-dihydro-2H-pyrrol-2-one, an important building block of the antidiabetic drug glimepiride, has been accomplished. Key features are the synthesis of 3-methyl-4-hydroxy-2-butenolide in water and triflic acid mediated N-benzyl lactam N-deprotection. The main advantages of this process are the scalable synthetic route and decreased number of reaction steps, which paves the way for the industrial-scale synthesis of 3-ethyl-4-methyl-1,5-dihydro-2H-pyrrol-2-one.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0040-1707344.
- Supporting Information